Cardinal Health Inc. (CAH)
Should Value Investors Buy Cardinal Health (CAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Cardinal Health (CAH) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Down 14.1% in 4 Weeks, Here's Why You Should You Buy the Dip in Cardinal (CAH)
The heavy selling pressure might have exhausted for Cardinal (CAH) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Here's Why Cardinal Health (CAH) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Brokers Suggest Investing in Cardinal (CAH): Read This Before Placing a Bet
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes"
Cardinal (CAH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Cardinal (CAH) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Cardinal (CAH) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Cardinal Health Among 9 Companies To Announce Dividend Increases In The First Half Of May
As expected, Apple focused on share buybacks, increasing its share repurchase authorization by $100 billion while announcing a 4% dividend increase. Looking forward to the first half of May, Cardinal Health is expected to announce a modest 1–3% dividend increase, maintaining its pattern of minimal payout growth despite strong EPS expansion. Strong EPS growth—9% in 2025 and 23–25% projected for 2026—has not translated into higher dividend increases for CAH, as management prioritizes repurchases.
Cardinal Health, Inc. (CAH) Q3 2026 Earnings Call Transcript
Cardinal Health, Inc. (CAH) Q3 2026 Earnings Call Transcript
CAH Gains on Q3 Earnings Beat, '26 EPS View Up Despite Revenue Miss
Cardinal Health beats Q3 EPS estimates and raises 2026 outlook, fueled by pharma and specialty growth despite a revenue miss.
Cardinal (CAH) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Cardinal (CAH) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Cardinal Health (CAH) Q3 Earnings Beat Estimates
Cardinal Health (CAH) came out with quarterly earnings of $3.17 per share, beating the Zacks Consensus Estimate of $2.8 per share. This compares to earnings of $2.35 per share a year ago.
